These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30720130)

  • 21. Increased expression of LINC01510 predicts poor prognosis and promotes malignant progression in human non-small cell lung cancer.
    Li J; Wei L
    Biomed Pharmacother; 2019 Jan; 109():519-529. PubMed ID: 30399588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
    Zhu J; Zhang Y; Yang X; Jin L
    Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric Adenocarcinoma Predictive Long Intergenic Non-Coding RNA Promotes Tumor Occurrence and Progression in Non-Small Cell Lung Cancer via Regulation of the miR-661/eEF2K Signaling Pathway.
    Gu H; Chen J; Song Y; Shao H
    Cell Physiol Biochem; 2018; 51(5):2136-2147. PubMed ID: 30522114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
    Huang J; Sun C; Wang S; He Q; Li D
    Mol Biosyst; 2015 Jul; 11(7):2051-9. PubMed ID: 25988292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRPV1 inhibition suppresses non-small cell lung cancer progression by inhibiting tumour growth and enhancing the immune response.
    Wang Y; Zhang Y; Ouyang J; Yi H; Wang S; Liu D; Dai Y; Song K; Pei W; Hong Z; Chen L; Zhang W; Liu Z; Mcleod HL; He Y
    Cell Oncol (Dordr); 2024 Jun; 47(3):779-791. PubMed ID: 37902941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.
    Sun L; Yuan H; Burnett J; Gasparyan M; Zhang Y; Zhang F; Yang Z; Ran Y; Sun D
    Int J Med Sci; 2019; 16(1):68-74. PubMed ID: 30662330
    [No Abstract]   [Full Text] [Related]  

  • 28. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
    Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer.
    Shi X; Sun M; Liu H; Yao Y; Kong R; Chen F; Song Y
    Mol Carcinog; 2015 Jun; 54 Suppl 1():E1-E12. PubMed ID: 24357161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.
    Yue W; Zhao X; Zhang L; Xu S; Liu Z; Ma L; Jia W; Qian Z; Zhang C; Wang Y; Yang X
    Clin Lung Cancer; 2011 Jan; 12(1):43-50. PubMed ID: 21273179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RAD52 motif‑containing protein 1 promotes non‑small cell lung cancer cell proliferation and survival via cell cycle regulation.
    Xu G; Du J; Wang F; Zhang F; Hu R; Sun D; Shen J
    Oncol Rep; 2018 Aug; 40(2):833-840. PubMed ID: 29845285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC.
    Xiao G; Gao X; Sun X; Yang C; Zhang B; Sun R; Huang G; Li X; Liu J; Du N; Liu D; Liang R; Ren H; Qin S
    Oncol Rep; 2017 Aug; 38(2):1190-1198. PubMed ID: 28656290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.
    Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP
    Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHAF1B knockdown blocks migration in a hepatocellular carcinoma model.
    Peng X; Fu H; Yin J; Zhao Q
    Oncol Rep; 2018 Jul; 40(1):405-413. PubMed ID: 29767268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non‑small cell lung cancer cells.
    Gao L; Yang T; Zhang S; Liang Y; Shi P; Ren H; Hou P; Chen M
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.
    Wei K; Pan C; Yao G; Liu B; Ma T; Xia Y; Jiang W; Chen L; Chen Y
    Cell Physiol Biochem; 2017; 44(4):1545-1558. PubMed ID: 29197876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of WDR79 in non-small cell lung cancer is linked to tumour progression.
    Sun Y; Yang C; Chen J; Song X; Li Z; Duan M; Li J; Hu X; Wu K; Yan G; Yang C; Liu J; Tan W; Ye M
    J Cell Mol Med; 2016 Apr; 20(4):698-709. PubMed ID: 26849396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of TRIM28 inhibits growth and increases apoptosis of nude mice with non‑small cell lung cancer xenografts.
    Liu L; Zhang L; Wang J; Zhao X; Xu Q; Lu Y; Zuo Y; Chen L; Du J; Lian Y; Zhang Q
    Mol Med Rep; 2018 Jan; 17(1):835-842. PubMed ID: 29115614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
    Jing H; Xia H; Qian M; Lv X
    Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
    Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
    Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.